Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mattson

Showing results (61-70 of 190) with videos related to

Pageof 19
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Radiosensitivity of mesothelioma cell linesA M Häkkinen, A Laasonen, K Linnainmaa, et al.
British Journal of Cancer|January 1, 1997
Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesotheliomaA M Björkqvist, L Tammilehto, S Anttila, et al.
Seminars in Oncology|April 1, 1988
Trimetrexate and cyclophosphamide for metastatic inoperable nonsmall cell lung cancerK Mattson, P Maasilta, L Tammilehto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
N-acetylcysteine in combination with radiotherapy in the treatment of non-small cell lung cancer: a feasibility studyP Maasilta, L R Holsti, P Blomqvist, et al.
The European Respiratory Journal|January 1, 1991
Radiographic chest assessment of lung injury following hemithorax irradiation for pleural mesotheliomaP Maasilta, L Kivisaari, L R Holsti, et al.
American Journal of Clinical Oncology|December 1, 1987
Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesineA Niiranen, L R Holsti, M Salmo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 1998
Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLCO P Isokangas, H Joensuu, M Halme, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 13, 2001
Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesotheliomaA Knuuttila, L Kivisaari, A Kivisaari, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesotheliomaA Knuuttila, M Halme, L Kivisaari, et al.
Cancer Genetics and Cytogenetics|August 1, 1992
Chromosome number correlates with survival in patients with malignant pleural mesotheliomaM Tiainen, J Rautonen, S Pyrhönen, et al.
Pageof 19

Showing results (61-70 of 190) with videos related to

Sort By:
Pageof 19
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Radiosensitivity of mesothelioma cell linesA M Häkkinen, A Laasonen, K Linnainmaa, et al.
British Journal of Cancer|January 1, 1997
Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesotheliomaA M Björkqvist, L Tammilehto, S Anttila, et al.
Seminars in Oncology|April 1, 1988
Trimetrexate and cyclophosphamide for metastatic inoperable nonsmall cell lung cancerK Mattson, P Maasilta, L Tammilehto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
N-acetylcysteine in combination with radiotherapy in the treatment of non-small cell lung cancer: a feasibility studyP Maasilta, L R Holsti, P Blomqvist, et al.
The European Respiratory Journal|January 1, 1991
Radiographic chest assessment of lung injury following hemithorax irradiation for pleural mesotheliomaP Maasilta, L Kivisaari, L R Holsti, et al.
American Journal of Clinical Oncology|December 1, 1987
Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesineA Niiranen, L R Holsti, M Salmo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 1998
Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLCO P Isokangas, H Joensuu, M Halme, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 13, 2001
Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesotheliomaA Knuuttila, L Kivisaari, A Kivisaari, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesotheliomaA Knuuttila, M Halme, L Kivisaari, et al.
Cancer Genetics and Cytogenetics|August 1, 1992
Chromosome number correlates with survival in patients with malignant pleural mesotheliomaM Tiainen, J Rautonen, S Pyrhönen, et al.
Pageof 19